Authors: Schrag, SJ Pena, C Fernandez, J Sanchez, J Gomez, V Perez, E Feris, JM Besser, RE

Citation: Sj. Schrag et al., Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage - A randomized trial, J AM MED A, 286(1), 2001, pp. 49-56

Authors: Schrag, SJ Whitney, CG Schuchat, A

Citation: Sj. Schrag et al., Neonatal group B streptococcal disease: How infection control teams can contribute to prevention efforts, INFECT CONT, 21(7), 2000, pp. 473-483

Authors: Schrag, SJ Beall, B Dowell, SF

Citation: Sj. Schrag et al., Limiting the spread of resistant pneumococci: Biological and epidemiologicevidence for the effectiveness of alternative interventions, CLIN MICROB, 13(4), 2000, pp. 588

Authors: Schrag, SJ Besser, RE Olson, C Burns, JC Arguin, PM Gimenez-Sanchez, F Stevens, VA Pruckler, JM Fields, BS Belay, ED Ginsberg, M Dowell, SF

Citation: Sj. Schrag et al., Lack of association between Kawasaki syndrome and Chlamydia pneumoniae infection: an investigation of a Kawasaki syndrome cluster in San Diego County, PEDIAT INF, 19(1), 2000, pp. 17-22

Authors: Schrag, SJ Zywicki, S Farley, MM Reingold, AL Harrison, LH Lefkowitz, LB Hadler, JL Danila, R Cieslak, PR Schuchat, A

Citation: Sj. Schrag et al., Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis, N ENG J MED, 342(1), 2000, pp. 15-20

Authors: Schrag, SJ Rota, PA Bellini, WJ

Citation: Sj. Schrag et al., Spontaneous mutation rate of measles virus: Direct estimation based on mutations conferring monoclonal antibody resistance, J VIROLOGY, 73(1), 1999, pp. 51-54